PFG Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

PFG Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$862K	Buy	+15,892	New	+$715K	0.04%	402
2023 Q3	–	Sell	-9,306	Closed	-$317K	–	603
2023 Q2	$317K	Sell	9,306 -1,639	-15%	-$51.5K	0.02%	506
2023 Q1	$329K	Buy	10,945 +18	+0.2%	+$558	0.03%	467
2022 Q4	$308K	Sell	10,927 -798	-7%	-$25.3K	0.03%	446
2022 Q3	$385K	Sell	11,725 -2,711	-19%	-$100K	0.04%	366
2022 Q2	$455K	Sell	14,436 -25,184	-64%	-$881K	0.05%	260
2022 Q1	$1.82M	Sell	39,620 -10,909	-22%	-$520K	0.18%	123
2021 Q4	$3.09M	Sell	50,529 -10,500	-17%	-$726K	0.3%	85
2021 Q3	$4.56M	Buy	61,029 +4,003	+7%	+$336K	0.5%	37
2021 Q2	$5.28M	Buy	57,026 +12,216	+27%	+$1.04M	0.6%	29
2021 Q1	$3.98M	Buy	44,810 +14,144	+46%	+$1.4M	0.51%	42
2020 Q4	$2.86M	Buy	30,666 +15,582	+103%	+$1.24M	0.48%	53
2020 Q3	$1.06M	Buy	15,084 +1,374	+10%	+$80.5K	0.2%	131
2020 Q2	$764K	Buy	13,710 +1,716	+14%	+$73.6K	0.17%	151
2020 Q1	$463K	Buy	+11,994	New	+$401K	0.12%	183

Other funds holding ARKG

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Florin Court Capital London, United Kingdom $97M AUM 40.08% 1-Year Est. Return

NTV Asset Management Charleston, West Virginia $1.08B AUM 23.94% 1-Year Est. Return

Midwest Financial Partners Investments St. Cloud, Minnesota $260M AUM 10.89% 1-Year Est. Return

Canal Insurance Company Greenville, South Carolina $426M AUM 30.47% 1-Year Est. Return

Gimbal Financial Carmel, Indiana $172M AUM

Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return

Riggs Asset Management Dallas, Pennsylvania $541M AUM 40.97% 1-Year Est. Return

PFG Advisors's ARKG Position: Q3 2026 in Review

PFG Advisors opened a new position in ARK Genomic Revolution ETF (ARKG) in Q3 2026: 15,892 shares worth $862K. The stake represents 0.04% of the portfolio and ranks #402 among its holdings. This is a return to the name: PFG Advisors previously reported a position in ARKG as recently as Q2 2023.

PFG Advisors first reported a position in ARKG in Q1 2020 and has held it in 15 quarters since. The position peaked at $5.28M in Q2 2021. 169 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.

PFG Advisors held 15,892 shares of ARK Genomic Revolution ETF worth $862K as of Q3 2026.
ARK Genomic Revolution ETF was a new PFG Advisors position in Q3 2026.
ARK Genomic Revolution ETF made up 0.04% of PFG Advisors's portfolio in Q3 2026, its #402 holding.
PFG Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2020 and has held it in 15 quarters since.
PFG Advisors's ARK Genomic Revolution ETF position peaked at $5.28M in Q2 2021.
169 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.

Based on PFG Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.